Table 2.
Prior Therapy | Number of Patients |
---|---|
Bortezomib, Lenalidomide, Dexamethasone (BLD) | 15 |
Bortezomib, Cyclophosphamide, Dexamethasone (BCD) | 9 |
Bortezomib, Cyclophosphamide, Liposomal-doxarubicin, Dexamethasone (BCLD) | 1 |
Lenolidomide, Dexamethasone (LD) | 1 |
Bortezomib, Dexamethasone (BD) | 1 |
BCD; BLD | 1 |
Bortezomib, Melphalan;BCD | 1 |
Bortezomib, Thalidomide, Dexamethasone (BTD); LD | 1 |
BD; BLD | 1 |
BCLD; BTD | 1 |
LD; BLD; BCD | 1 |
BCLD; BTD; BLD-Cisplatin, Adriamycin, Cyclophosphamide, Etoposide | 1 |